Please select the arm or intervention descriptions that belong to the clinical trial below.
Title: Prospective Randomized Comparison of ABVD Versus BEACOPP Chemotherapy With or Without Radiotherapy for Advanced Stage or Unfavorable Hodgkin's Lymphoma (HL)
Brief Summary: The choice of a preferred first-line treatment requires balancing the desire for optimal disease control with the occurrence of early and late treatment-related effects. To fully assess this balance, the treatment decision process should ideally take into account the outcome following a consistent second-line therapy, in particular when tolerated, widely applicable and highly effective salvage regimens exist, like in Hodgkin lymphoma failing initial chemotherapy.


Options:
A: Arm Label: A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Adriamycin, Drug: Bleomycin, Drug: Vinblastine, Drug: DTIC, Radiation: radiation therapy | Arm Label: C; Type: EXPERIMENTAL; Interventions: Drug: Adriamycin, Drug: Bleomycin, Drug: Etoposide, Drug: Procarbazine, Drug: Prednisone, Drug: Vincristine, Radiation: radiation therapy | Arm Label: B; Type: EXPERIMENTAL; Interventions: Drug: Adriamycin, Drug: Bleomycin, Drug: Vinblastine, Drug: DTIC, Radiation: radiation therapy | Arm Label: D; Type: EXPERIMENTAL; Interventions: Drug: Adriamycin, Drug: Bleomycin, Drug: Etoposide, Drug: Procarbazine, Drug: Prednisone, Drug: Vincristine, Radiation: radiation therapy | Intervention Type: DRUG; Name: Adriamycin; Assigned to Arm(s): A, B, C, D | Intervention Type: DRUG; Name: Bleomycin; Assigned to Arm(s): A, B, C, D | Intervention Type: DRUG; Name: Vinblastine; Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: DTIC; Assigned to Arm(s): A, B | Intervention Type: DRUG; Name: Etoposide; Assigned to Arm(s): C, D | Intervention Type: DRUG; Name: Procarbazine; Assigned to Arm(s): C, D | Intervention Type: DRUG; Name: Prednisone; Assigned to Arm(s): C, D | Intervention Type: DRUG; Name: Vincristine; Assigned to Arm(s): C, D | Intervention Type: RADIATION; Name: radiation therapy; Assigned to Arm(s): A, B, C, D
B: Arm Label: Arm A (ABVD); Type: EXPERIMENTAL; Interventions: Drug: Doxorubicin, Drug: Bleomycin, Drug: Vinblastine, Drug: Dacarbazine, Radiation: Radiotherapy | Arm Label: Arm B (Stanford V); Type: ACTIVE_COMPARATOR; Interventions: Drug: Doxorubicin, Drug: Bleomycin, Drug: Vinblastine, Drug: Vincristine, Drug: Mechlorethamine, Drug: Etoposide, Drug: Prednisone, Drug: Cyclophosphamide, Radiation: Radiotherapy | Intervention Type: DRUG; Name: Doxorubicin; Assigned to Arm(s): Arm A (ABVD), Arm B (Stanford V) | Intervention Type: DRUG; Name: Bleomycin; Assigned to Arm(s): Arm A (ABVD), Arm B (Stanford V) | Intervention Type: DRUG; Name: Vinblastine; Assigned to Arm(s): Arm A (ABVD), Arm B (Stanford V) | Intervention Type: DRUG; Name: Dacarbazine; Assigned to Arm(s): Arm A (ABVD) | Intervention Type: DRUG; Name: Vincristine; Assigned to Arm(s): Arm B (Stanford V) | Intervention Type: DRUG; Name: Mechlorethamine; Assigned to Arm(s): Arm B (Stanford V) | Intervention Type: DRUG; Name: Etoposide; Assigned to Arm(s): Arm B (Stanford V) | Intervention Type: DRUG; Name: Prednisone; Assigned to Arm(s): Arm B (Stanford V) | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): Arm B (Stanford V) | Intervention Type: RADIATION; Name: Radiotherapy; Assigned to Arm(s): Arm A (ABVD), Arm B (Stanford V)
C: Arm Label: Arm B; Type: EXPERIMENTAL; Interventions: Drug: Bleomycin, Drug: Etoposide, Drug: Doxorubicin, Drug: Cyclophosphamide, Drug: Vincristine, Drug: Procarbazine, Drug: Prednisone | Arm Label: Arm A; Type: ACTIVE_COMPARATOR; Interventions: Drug: Doxorubicin, Drug: Bleomycin, Drug: Vinblastine, Drug: Dacarbazine | Intervention Type: DRUG; Name: Bleomycin; Assigned to Arm(s): Arm B | Intervention Type: DRUG; Name: Etoposide; Assigned to Arm(s): Arm B | Intervention Type: DRUG; Name: Doxorubicin; Assigned to Arm(s): Arm B | Intervention Type: DRUG; Name: Cyclophosphamide; Assigned to Arm(s): Arm B | Intervention Type: DRUG; Name: Vincristine; Assigned to Arm(s): Arm B | Intervention Type: DRUG; Name: Procarbazine; Assigned to Arm(s): Arm B | Intervention Type: DRUG; Name: Prednisone; Assigned to Arm(s): Arm B | Intervention Type: DRUG; Name: Doxorubicin; Assigned to Arm(s): Arm A | Intervention Type: DRUG; Name: Bleomycin; Assigned to Arm(s): Arm A | Intervention Type: DRUG; Name: Vinblastine; Assigned to Arm(s): Arm A | Intervention Type: DRUG; Name: Dacarbazine; Assigned to Arm(s): Arm A
D: Intervention Type: BIOLOGICAL; Name: bleomycin sulfate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: doxorubicin hydrochloride; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: mechlorethamine hydrochloride; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: prednisone; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: procarbazine hydrochloride; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: vinblastine sulfate; Assigned to Arm(s): N/A | Intervention Type: DRUG; Name: vincristine sulfate; Assigned to Arm(s): N/A | Intervention Type: RADIATION; Name: radiation therapy; Assigned to Arm(s): N/A

Answer: C